Contact-force radiofrequency ablation of non-paroxysmal atrial fibrillation: improved outcomes with increased experience.
Chirag R BarbhaiyaRobert J KnottsKaty BockstallScott BernsteinDavid ParkDouglas HolmesAnthony AizerLarry A ChinitzPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2019)
While there was no difference in overall outcomes between CFS and non-CFS ablation using a stepwise linear approach in patients with NPAF, procedural efficacy of the second half of CFS patients was significantly improved compared to both the first half of CFS patients and all non-CFS patients. Lack of benefit seen in clinical trials using CFS technology may be related to operator inexperience with CFS ablation catheters at the time of the trials.
Keyphrases
- end stage renal disease
- atrial fibrillation
- radiofrequency ablation
- newly diagnosed
- clinical trial
- ejection fraction
- chronic kidney disease
- prognostic factors
- metabolic syndrome
- adipose tissue
- type diabetes
- patient reported outcomes
- acute coronary syndrome
- mitral valve
- patient reported
- insulin resistance
- venous thromboembolism
- double blind